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The disruption of brain networks is characteristic of neurodegenerative dementias. However, it is controversial whether changes in
connectivity reﬂect only the functional anatomy of disease, with selective vulnerability of brain networks, or the speciﬁc neuro-
physiological consequences of different neuropathologies within brain networks. We proposed that the oscillatory dynamics of
cortical circuits reﬂect the tuning of local neural interactions, such that different pathologies are selective in their impact on the
frequency spectrum of oscillations, whereas clinical syndromes reﬂect the anatomical distribution of pathology and physiological
change. To test this hypothesis, we used magnetoencephalography from ﬁve patient groups, representing dissociated pathological
subtypes and distributions across frontal, parietal and temporal lobes: amnestic Alzheimer’s disease, posterior cortical atrophy, and
three syndromes associated with frontotemporal lobar degeneration. We measured effective connectivity with graph theory-based
measures of local efﬁciency, using partial directed coherence between sensors. As expected, each disease caused large-scale changes
of neurophysiological brain networks, with reductions in local efﬁciency compared to controls. Critically however, the frequency
range of altered connectivity was consistent across clinical syndromes that shared a likely underlying pathology, whilst the local-
ization of changes differed between clinical syndromes. Multivariate pattern analysis of the frequency-speciﬁc topographies of local
efﬁciency separated the disorders from each other and from controls (accuracy 62% to 100%, according to the groups’ differences
in likely pathology and clinical syndrome). The data indicate that magnetoencephalography has the potential to reveal speciﬁc
changes in neurophysiology resulting from neurodegenerative disease. Our ﬁndings conﬁrm that while clinical syndromes have
characteristic anatomical patterns of abnormal connectivity that may be identiﬁed with other methods like structural brain
imaging, the different mechanisms of neurodegeneration also cause characteristic spectral signatures of physiological coupling
that are not accessible with structural imaging nor confounded by the neurovascular signalling of functional MRI. We suggest
that these spectral characteristics of altered connectivity are the result of differential disruption of neuronal microstructure and
synaptic physiology by Alzheimer’s disease versus frontotemporal lobar degeneration.
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Abbreviations: bvFTD = behavioural variant frontotemporal dementia; FTLD = frontotemporal lobar degeneration; MEG =
magnetoencephalography; MVAR = multivariate autoregressive modelling; navPPA = non-ﬂuent agrammatic variant of primary
progressive aphasia; PCA = posterior cortical atrophy; PDC = partial directed coherence; PSP = progressive supranuclear palsy
Introduction
The impact of neurodegeneration can be understood in
terms of its effect on the structure and function of brain
networks. For example, there are structural anatomical ﬁn-
gerprints for Alzheimer’s disease and frontotemporal de-
mentia, and disease-speciﬁc changes in their functional
connectivity with ‘epicentres’ of disease (Seeley et al.,
2009; Zhou et al., 2010; Crossley et al., 2014).
Moreover, the distribution of abnormal connectivity mir-
rors the anatomical and functional networks in health, sug-
gesting selective vulnerability of brain networks to
neuropathology (Pievani et al., 2011).
The evidence for network-speciﬁc changes in major
human dementia syndromes comes largely from functional
MRI. However, MRI indirectly examines the physiological
consequences of neuropathology. For example, in
Alzheimer’s disease misfolding and aggregation of amyl-
oid-b and microtubule-associated protein tau (MAPT),
occur in a cascade that ultimately impacts on synaptic func-
tion and cell survival (Spires-Jones and Hyman, 2014).
Functional MRI can detect the late consequences of this
cascade on connectivity (Bullmore and Sporns, 2009;
Fornito et al., 2015), but it is limited by slow and indirect
neurovascular signalling (Hillman, 2014; Tsvetanov et al.,
2015). In contrast, magnetoencephalography (MEG) and
EEG offer a temporal resolution that can resolve changes
in neural dynamics that are indistinguishable by functional
MRI, and that are independent of effects of age or medi-
cation on the neurovascular response (de Haan et al.,
2012a; Hughes et al., 2013; Tsvetanov et al., 2015).
Clinical research applications of EEG have reported fea-
tures that distinguish Alzheimer’s disease from controls
(Triggiani et al., 2017); predict the conversion from mild
cognitive impairment to dementia (Poil et al., 2013); and
provide pre-symptomatic markers of autosomal dominant
disease (Quiroz et al., 2011). In contrast, clinical EEGs of
frontotemporal dementia are often regarded as normal, al-
though abnormalities at the group level have been shown
(Chan et al., 2004). Beyond clinical applications, the spec-
tral and spatial resolution of MEG and EEG enables one to
test key hypotheses of human neurodegeneration; identify-
ing the reorganization of networks in dementia; and pro-
viding potential biomarkers for diagnosis, prognosis or
drug response (Hughes and Rowe, 2013; Hughes et al.,
2013, 2015; Maestu et al., 2015).
Here, we exploit the spatiotemporal precision of MEG to
build on preclinical models of dementia, and determine the
speciﬁcity of pathophysiological signatures of Alzheimer’s
disease pathology versus frontotemporal lobar degeneration
(FTLD). For example, transgenic rodent models of
Alzheimer’s disease have indicated speciﬁc alterations in
fast network dynamics, resulting in loss of gamma power
(30+ Hz) in cortical and hippocampal local networks
(Kurudenkandy et al., 2014). Analogous changes in net-
work dynamics can be identiﬁed in humans, noting that
the distribution of disease can vary between early medial-
temporal lobe changes in typical Alzheimer’s disease, versus
an occipito-parietal focus in the posterior cortical atrophy
(PCA) variant (Selkoe, 2002; Crutch et al., 2012; Pena-
Ortega et al., 2012). The behavioural variant of frontotem-
poral dementia (bvFTD), on the other hand, is often asso-
ciated with tauopathy in the absence of amyloid-b, for
which electrophysiological recordings in rodent tauopathy
models indicate power reductions in the lower frequency
bands; alpha (8–13Hz) and beta (14–30Hz) (Koss et al.,
2016). FTLD also encompasses the non-ﬂuent agrammatic
variant of primary progressive aphasia (navPPA) and pro-
gressive supranuclear palsy (PSP, Richardson’s syndrome),
which are both most commonly caused by primary tauo-
pathy but which differ in the severity and location of atro-
phy (Ghosh et al., 2012; Mandelli et al., 2016).
Our overarching hypothesis was that different neuro-
pathologies have characteristic physiological signatures,
which reﬂect both the anatomical distribution of pathology
and their impact on the oscillatory dynamics of cortical
circuits. We predicted that typical Alzheimer’s disease and
PCA would differ in the localization of their functional
effects, but that the changes in oscillatory dynamics
within affected regions would be similar. In contrast, we
predicted that three subtypes of FTLD would have different
spectral and spatial properties compared to Alzheimer’s dis-
ease, while their spectral properties may be similar to each
other albeit in different spatial distributions and with dis-
tinct clinical phenotypes. The signiﬁcance of MEG-based
differentiation of these ﬁve syndromes is not primarily for
utility as a diagnostic biomarker, in competition with other
biomarkers. Rather, it lies in establishing their pathophysio-
logical signatures in humans in vivo, extending the network
paradigm of neurodegeneration to the spectral domain, and
validating translational models of disease.
Our principle measure of network function was local ef-
ﬁciency, which indicates a network’s local information
transfer and resilience (Bullmore and Sporns, 2009; Stam,
2014). This measure is therefore ideally suited to examine
the effect of degenerative syndromes associated with re-
gional variations in pathology. Note that locality here
refers to topological locality, and not Euclidean locality
or physical proximity. The reorganization of brain net-
works can also be measured in terms of global properties
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(e.g. small worldness), or the changes in the properties of
hub regions that are critical for effective long-range inte-
gration (Crossley et al., 2014). However, we focus on local
efﬁciency as although neurodegeneration is diffuse, it is not
uniformly distributed: both frontotemporal dementia and
Alzheimer’s disease variants like PCA manifest clear re-
gional speciﬁcity, in keeping with their nomenclature.
Moreover, a potential advantage of the neurophysiological
approach is greater sensitivity to network reorganization
before extensive cell death leads to atrophy (Knight and
Verkhratsky, 2010; Palop and Mucke, 2010; Hughes
et al., 2013).
Materials and methods
Participants
Patients were enrolled from tertiary clinics at Cambridge
University Hospitals NHS Trust. Patients with Alzheimer’s dis-
ease included 13 with typical Alzheimer’s disease (McKhann
et al., 2011) and 11 with PCA (Crutch et al., 2012). Patients
with clinical syndromes associated with FTLD comprised 13
patients with bvFTD (Rascovsky et al., 2011), all with abnor-
mal structural MRI and evidence of progression; 15 with PSP
(Litvan et al., 1996) and 11 with navPPA (Gorno-Tempini
et al., 2011). The PSP cases meet the deﬁnition for probable
or deﬁnite PSP-Richardson’s syndrome under the revised diag-
nostic criteria (Ho¨glinger et al., 2017). Fifteen healthy adult
participants were recruited (11 males; age 59–85 years) with
no history of neurological or psychiatric illness. The study was
approved by the local Research Ethics Committee and written
informed consent was obtained in accordance with the stand-
ards of the Declaration of Helsinki. Patients undertook the
Mini-Mental State Examination (MMSE) and the revised
Addenbrooke’s cognitive examination (ACE-R). The clinical
and cognitive features of the patients are summarized in
Table 1.
Experimental design and data
acquisition
Figure 1 illustrates the ﬂow of the processes involved in the
data acquisition, preprocessing and analysis. All participants
rested with their eyes closed while MEG was continuously re-
corded at 1 kHz sampling rate from 204 planar gradiometers
using a Vectorview system (Elekta Neuromag) within a mag-
netically shielded room. The ﬁrst 30–40 s of data were dis-
carded to allow the participant to settle, resulting in 4min of
data per participant. Horizontal and vertical electrooculograms
(EOG) were recorded and the participants’ head position was
tracked with ﬁve head position indicator coils, localized in 3D
together with 100 head points for anatomical registration
using a 3D digitizer (Fastrak Polhemus, Inc.). The removal
of environmental artefacts and head position alignment used
the temporal extension of Signal Space Separation (tSSS) with
Elekta-Neuromag MaxFilter v.2.2. Oculomotor artefacts were
removed by independent component analysis, followed by pro-
jection out of the data of those independent components that
correlated highly with either of the two EOG signals (typically
1–3 independent components per participant) (Gonzalez-
Moreno et al., 2014).
To examine the effect of neurodegeneration on network con-
nectivity, we applied multivariate autoregressive modelling
(MVAR) to the root mean square of the two planar gradiom-
eters at each of the 102 locations around the head. One ad-
vantage of MVAR is that it ignores zero-lag correlations,
which include those arising from volume conduction of a
single brain source to multiple sensors. This reduces the need
for source reconstruction of the MEG data; an inverse problem
that cannot be solved without additional assumptions.
To reduce dimensionality and zero-lag co-linearity, and in-
crease Gaussianity, we performed principal components ana-
lysis on the root mean square data and retained the ﬁrst 60
principal components (which accounted for over 99% of the
total variance). The MVAR was ﬁtted to the lagged covariance
matrices using the Vieira-Morf method. For MVAR modelling,
an important step is to specify the model order, p (i.e. the
number of past samples needed to predict the current
sample). To ﬁnd the optimal balance between model ﬁt and
complexity, we used the Bayesian information criterion, which
resulted in an optimal model order of p = 8 for all groups. To
test whether the data were stationary we used the stability
index: data are stationary if and only if stability index50.
This conﬁrmed that the MVAR modelling did not signiﬁcantly
deviate from stationarity in any participant.
After projecting the ﬁtted MVAR parameters back into sensor
space, we estimated partial directed coherence (PDC) (Baccala´
and Sameshima, 2001; Schelter et al., 2006; Williams et al.,
2014) between all 102 sensor locations. PDC is a frequency-
speciﬁc measure of connectivity that preserves the directionality
of interactions, and has been shown to provide good reliability
for group studies (Colclough et al., 2016). PDC was estimated
every 0.1Hz from 1 to 80Hz to create a 102  102 matrix for
each of 800 frequencies, using the signiﬁcance for which the P-
values threshold was then binarized by taking the top 15% of
signiﬁcant connections for each frequency bin (i.e. a threshold of
85%, based on simulations below). The binary connectivity
matrices were then used to estimate local efﬁciency for each
node (location) and frequency.
Simulations
To validate the ability of MVAR modelling to detect local
network difference in functional segregation, we created 20
source-level networks with low mean local efﬁciency and 20
with high mean local efﬁciency. Each of the networks had six
sources that differed in which six of the possible 30 connec-
tions existed. The sources corresponded to dipoles positioned
on the cortical surface of a single-subject brain that was
warped to MNI space. The dipoles were those closest to
points in left and right prefrontal cortex (MNI coordinates
of [60 +10 +20]), left and right parietal cortex (MNI coord-
inates of [50  70 +30]) and left and right ventral temporal
cortex (MNI coordinates of [30  70 0]). Multivariate time
series of samples, with a sampling frequency of 1 kHz, were
generated from an MVAR process with a zero-mean, unit vari-
ance independent Gaussian innovation for each source. These
time series were then projected through a forward model that
was based on a deformed sphere approximation to the indi-
vidual’s inner skull surface, which had been co-registered with
the MEG sensors from a real recording from the Elekta
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VectorView system. We added independent Gaussian noise to
each of the simulated gradiometer time series, with a variable
signal-to-noise ratio (SNR) based on the standard deviation
(SD) of signal to noise, with SNR values of [0.1, 1, 3, 10,
Inf] (where Inf means no added sensor noise). We then ﬁtted
the sensor-level data with an MVAR model, and generated
PDC matrices to assess whether sensor-level networks pre-
served differences in mean local efﬁciency of the underlying
source-level networks. These assessments were performed
with PDC matrices binarized with thresholds of 85%, 95%,
and 99%, respectively.
Statistical analysis
To correct for multiple tests across sensors and frequencies in the
MEG analysis, we projected the 102 sensor locations onto a 2D
plane, and interpolated their local efﬁciency values onto a
64  64 grid using SPM8 (http://www.ﬁl.ion.ucl.ac.uk/spm), re-
sulting in a 3D scalp  frequency image (64  64  800), which
was smoothed with a Gaussian kernel (8mm  8mm  8Hz).
Pairwise differences between groups were then assessed with
Statistical non-Parametric Mapping (SnPM, http://warwick.ac.
uk/snpm), which used 5000 permutations to generate pseudo-T
distributions that are robust to small sample sizes and do not
assume Gaussian error. A cluster-based extension was imple-
mented to detect statistically signiﬁcant clusters on t-maps
(Hayasaka and Nichols, 2004). The cluster value was set to con-
form to the 95th percentile of the data-driven distribution, and
signiﬁcant clusters were set to P50.05. For interpretation, the
frequencies were subdivided into delta (54Hz), theta (4–7Hz),
alpha (8–13Hz), beta (14–30Hz), gamma (30–50Hz), and high-
gamma activity (450Hz) bands.
Classification of participants
In the ﬁnal analyses, we used multivariate pattern classiﬁcation
to identify the distinctions between two or more groups,
enabling subject-speciﬁc group assignment based on the
spatio-spectral characteristics of the networks’ local efﬁciency.
Pattern recognition was implemented in MATLAB (R2012b;
Mathworks, Natick, MA) using the Mania toolbox (https://
bitbucket.org/grotegerd/mania), which incorporates the
LIBSVM software library for the kernel-based support vector
classiﬁcation used (https://www.csie.ntu.edu.tw/cjlin/libsvm/).
Support vector machines automatically calculate decision
boundaries (hyperplanes) in a high-dimensional feature
space based on training data with known outcome; new data
are then placed into this space and outcome (prediction accur-
acy) determined according to its position relative to the
hyperplane.
We used linear kernels for the support vector machine clas-
siﬁcation with parameters bounded between (0,1).
Before classiﬁcation, we extracted low dimensional data fea-
tures to improve performance, by using (i) a Z-statistic that
was calculated over every voxel; and (ii) principal components
analysis of the 3D frequency  scalp image of local efﬁciency.
We applied leave-one-out cross-validation, iteratively dividing
the data into separate training and testing sets with balanced
groups and re-ran this iteration 10-fold to ensure stability.
Finally, the classiﬁcation performance from the support
vector machine is described in terms of the area under the
curve (AUC) of a receiver operating characteristic (ROC).
Figure 1 Data analysis pipeline. Clockwise from top:
Preprocessing, to remove biological artefacts using MaxFilter and
independent component analysis denoising; estimation of effective
connectivity using MVAR; compiling the association matrix between
sensors by PDC; applying a statistical threshold to create a binarized
graph, represented by the connectivity matrix; graph network ana-
lysis to estimate local efficiency; and group classification using a
support vector machine (SVM).
Table 1 Clinical and neuropsychological data for patient participants
Group Controls tAD PCA BvFTD NavPPA PSP-RS
n 15 13 11 13 11 15
Age 66.3  5.9 71.3  7.4 60.5  4.5* 64.3  6.9 72  8.7 67.9  6.5
MMSE (0–30) 29.4  0.7 25.0  3.2*** 19.6  6.0*** 24.6  3.8*** 27.9  2.2* 27.0  2.8**
ACE-R (0–100) 96.5  4.4 71.5  8.2*** 53.7  21.3*** 71.8  14.8*** 84.3  11.6** 83.2  7.9***
ACE-R memory (0–26) 25.2  1.0 12.7  3.6*** 13.6  7.8*** 17.9  5.5*** 21.6  6.9 22.0  4.0**
Data are presented as mean  SD.
ACE-R = revised Addenbrooke’s Cognitive Examination, total (0–100) and its memory subscale (0–26); MMSE = Mini-Mental State Examination; RS = Richardson’s syndrome;
tAD = typical amnestic Alzheimer’s disease.
Differences between each patient group and controls: *P5 0.05; **P5 0.01; ***P5 0.001 uncorrected.
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Results
A summary of demographic and clinical measures for the
patient groups is reported in Table 1. Across the ﬁve clin-
ical groups and controls, there was a group-wise difference
in age P5 0.05. However, Tukey HSD tests and Holm
correction for multiple comparisons, conﬁrmed that only
the PCA group were distinct in age, being younger (Table
1). All groups differed from controls in MMSE and ACE-R
scores, as expected (Table 1).
Figure 2 shows sections through the 3D scalp frequency
images of statistical differences between groups in local ef-
ﬁciency. Compared to healthy control subjects, patients
with typical Alzheimer’s disease reduced local efﬁciency
over temporal cortex (Fig. 2A). This effect was not equiva-
lent across all frequencies, but was observed in the gamma
range. The PCA variant of Alzheimer’s disease also caused
a similar reduction in gamma band local efﬁciency, but in a
different distribution that lay over more posterior regions
(Fig. 2B).
A physiologically distinct signature was observed for the
FTLD syndromes. For both PSP and bvFTD (Fig. 2C and
D), local efﬁciency was reduced in lower frequencies, ex-
tending from delta through alpha to low gamma. These
changes were evident over frontal cortex. While navPPA
showed a similar reduction at low frequencies particularly
in the delta/theta range, the distribution of the changes was
different to that seen in bvFTD and PSP, focused on centro-
parietal regions (Fig. 2E).
Figure 3 shows ROCs for each binary classiﬁcation of
patient groups, based on the spatial and spectral
distributions of local efﬁciency. Across all the comparisons
of Alzheimer’s disease variants versus FTLD variants, clas-
siﬁcation performance (AUC) ranged from 0.78 to 1. AUC
for distinguishing between the two Alzheimer’s disease vari-
ants typical Alzheimer’s disease and PCA was 0.74, while
that for distinguishing the three frontotemporal dementia
variants ranged from 0.62 (bvFTD versus PSP) to 1
(bvFTD versus navPPA).
Supplementary Fig. 1 shows ROCs for classiﬁcation of
each patient group versus controls, based on the spatial
and spectral distributions of local efﬁciency. The differ-
ence was highest for bvFTD group followed by typical
Alzheimer’s disease, with classiﬁcation performance
(AUC) at 0.96 and 0.85, respectively, and above-chance
lower classiﬁcation rates for PSP (0.76), navPPA (0.63)
and PCA (0.60).
From the simulations, we conﬁrmed that differences in
mean local efﬁciency of the source-level networks were pre-
served in mean local efﬁciency of the corresponding sensor-
level networks, at least for SNR levels of 3 and above when
thresholding at 85% and 95% (Supplementary Table 1).
Supplementary Fig. 2 illustrates this graphically on an ex-
ample of a low mean local efﬁciency and a high mean local
efﬁciency network.
Data availability
Anonymized data will be shared on request from a quali-
ﬁed investigator for purposes of replicating procedures and
results, and will be shared on request from a qualiﬁed
investigator for other non-commercial research purposes
within the limits of participants’ consent.
Figure 2 3D scalp-frequency images of local efficiency. The schematic (top left) indicates the three projections: the topography (Top) for
each frequency (1–80 Hz), an anterior-posterior (AP) projection, separating frequency but collapsing over left–right axis, and a ‘lateral’ view,
separating by frequency but collapsing over anterior-posterior axis. The five subplots (A–E) indicate the T-value for the difference in local
efficiency for each patient group versus controls (colour bar on right). The cross-hair shows the peak T-statistic, while the black outline indicates
regions surviving a cluster-corrected threshold of P5 0.05.
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Discussion
We have identiﬁed distinctive neurophysiological signatures
associated with ﬁve neurodegenerative disorders resulting
from Alzheimer’s disease and FTLD. The signatures are
characterized in terms of both the spatial and frequency
proﬁles of local efﬁciency in brain networks (local in topo-
logical terms). The anatomical distribution of changes in
local efﬁciency across the ﬁve syndromes was predicted
by the functional anatomy of their principal cognitive def-
icits. However, the disorders were also distinguished by
their spectral pattern of connectivity, according to the
likely underlying neuropathology.
In recent years the majority of MEG-based dementia-
related studies have focused on potential diagnostic or
prognostic biomarker utility (Stam, 2014). We conﬁrm
that the spectral dynamics and topography of local efﬁ-
ciency enabled classiﬁcation of patients using a simple ma-
chine-learning approach, with highest accuracy for
classiﬁcation between disorders. However, in the following
discussion, we evaluate our results in relation to Alzheimer
pathology, FTLD and the insights into pathogenic mechan-
isms from a network-based approach.
We focus on local network efﬁciency as one of the stron-
gest indicators of underlying pathology in Alzheimer’s dis-
ease and frontotemporal dementia (Stam, 2014; Medaglia
et al., 2017). Other graph network metrics have been re-
ported to be sensitive to the effects of neurodegeneration,
including measures of global integration or organization.
For example, previous MEG studies have shown the im-
portance of network modularity and of hub connections in
Alzheimer’s disease (de Haan et al., 2012b; Stam, 2014),
while a multi-layer frequency-band approach reveals the
disruption of hubs in Alzheimer’s disease patients (Yu
et al., 2017). Recent simulations demonstrate the link be-
tween directed functional connectivity and hubs (Moon
et al., 2015; Meier et al., 2017). This challenges the
simple dichotomy between ‘local’ or ‘global’ integration,
as hubs are themselves unevenly distributed yet inﬂuence
global connectivity (Stam, 2014). Conversely, the changes
in local efﬁciency we observed in Alzheimer’s disease are
widespread across the brain. Distributed changes in local
efﬁciency metrics may also contribute to part of the fre-
quently reported change in global efﬁciency and hub con-
nectivity in multiple neurological disorders (Crossley et al.,
2014). For example, closeness centrality is a characteristic
of hubs that is directly proportional to their local efﬁciency
(Sporns et al., 2007). Our results highlight the distributed
disruption of characteristic spectral signatures of physio-
logical coupling in neurodegenerative disorders.
Additionally, the local efﬁciency metric signiﬁes tolerance
in a network to a node’s removal i.e. a subgraph or a local
network’s vulnerability is related to the reduction of the
local efﬁciency of its contributing regions or nodes
(Latora and Marchiori, 2001; Medaglia et al., 2017).
This is of special interest in view of the impact of
neuropathological burden as measured by PET on connect-
ivity (Cope et al., 2018).
While network degeneration can be characterized at the
microscopic level, or at the level of global brain function,
we measured network dynamics at an intermediate scale, to
reﬂect the regional variations in pathology in each of the
ﬁve disorders. In the context of brain network dynamics,
we conﬁrmed the hypothesis that disorders that share a
common underlying pathology have a similar spectral sig-
nature of altered connectivity, regardless of phenotype. This
neurophysiological ﬁnding is distinct from the previously
established relationships between the structural connec-
tome, pathology and syndrome (Raj et al., 2012; Zhou
et al., 2012).
Alzheimer’s disease
Previous work in Alzheimer’s disease models and patients
has demonstrated reductions in relative spectral power in
high beta-gamma bands (Poza et al., 2007), despite meth-
odological differences between electrophysiological studies
(Dauwels et al., 2010). For example, in a network analysis
using EEG, Petersen et al. (2001) found small-worldness
of networks in the gamma band correlated with cognitive
performance in prodromal Alzheimer’s disease. Preclinical
models have investigated the aetiology of these changes,
including the analogous loss of gamma power and theta-
gamma coupling in cortical and hippocampal local net-
works in transgenic mouse models (Kurudenkandy et al.,
2014). For example, amyloid-b suppresses power in the
beta-gamma frequency range from entorhinal cortex and
induces desynchronization of pyramidal cells with a shift
of the excitatory-inhibitory equilibrium (Pena-Ortega et al.,
2012; Kurudenkandy et al., 2014). Neurodegenerative dis-
ease processes not only reduce synaptic density on pyr-
amidal cells, and their local interactions with inhibitory
interneurons, but also reduce neurotransmitters such as
GABA (Selkoe, 2002; Huey et al., 2006). Given the key
role of GABA in driving the gamma response in humans
(Muthukumaraswamy, 2014), our observations may
result from neurochemical as well as structural changes
in cortical networks, in typical Alzheimer’s disease and
PCA.
While PCA and typical Alzheimer’s disease were both
associated with similar changes in spectral density, they
had different scalp distributions of abnormality that re-
ﬂected the known distribution of underlying pathology,
with a parietal peak for PCA and predominantly tem-
poral distribution for typical Alzheimer’s disease, in keep-
ing with our principal hypothesis. The regional
distribution of abnormal MEG-based connectivity
cannot be equated with MRI or PET ﬁndings. For ex-
ample, our planar gradiometers will be relatively insensi-
tive to bilateral precuneus pathology in Alzheimer’s
disease by virtue of depth and orientation. The abnormal
local efﬁciency in typical Alzheimer’s disease also appears
to be more extensive on the left, as has been noted before
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(Long et al., 2013), but such laterality effects should be
viewed with caution, without inferring unilateral path-
ology: indeed by the stage of clinically diagnosed, symp-
tomatic Alzheimer’s disease, both amyloid and tau
pathologies are likely to be bilateral and widespread
(Jagust, 2016; Ossenkoppele et al., 2016; Passamonti
et al., 2017). If spatio-temporal connectivity signatures
are to provide a framework to understand multiple neu-
rodegenerative disorders, complementary signatures are
predicted for other pathologies and syndromes, to
which we turn in the next section.
Frontotemporal lobar degeneration
syndromes
We studied three syndromes associated with FTLD: bvFTD,
navPPA and classical PSP (Richardson’s syndrome). The
clinicopathological correlation of PSP is very high, with
90–95% of cases due to a glioneuronal 4-repeat tauopathy
(Litvan et al., 1996; Frank et al., 2007). Eleven of our PSP
patients have since died, of whom seven donated their
brain to the Cambridge Brain Bank: all seven had patho-
logical conﬁrmation of PSP. MRI studies reveal PSP-related
Figure 3 ROC curves illustrate the performance of the support vector machine classifier following principle component
feature extraction for binary classifications between each pair of patient groups. The classification performance between patient
groups is summarized by the area under the curve (AUC, inset). AD = Alzheimer disease.
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atrophy of medial frontal cortex (Ghosh et al., 2012) and
the loss of frontocentral local efﬁciency in Fig. 2 accords
with this structural change. The MEG analysis revealed a
selective loss in low frequency connectivity up to the high
beta range.
NavPPA has weaker clinicopathological correlations, but
it is also associated with tauopathy in the majority of cases,
while a minority have TDP-43 pathology (Gorno-Tempini
et al., 2011). Atrophy is typically not severe. BvFTD is the
most neuropathologically diverse form, and may arise from
3-repeat or 4-repeat tauopathy or TDP-43 pathology
(Boeve, 2007). The clinical syndrome is united by speciﬁc
and severe layer II/III atrophy of temporal poles, plus mod-
erate to severe atrophy of orbital and ventral frontal cortex
(Hughes et al., 2015). Like PSP, both navPPA and bvFTD
reduced the local efﬁciency in the delta and beta bands, but
the spatial and temporal characteristics of these changes
were speciﬁc, with near complete separation of bvFTD
and navPPA from the other syndromes (Fig. 3) reinforcing
the multimodal separation of Alzheimer’s disease from
navPPA (Hu et al., 2010).
During our classiﬁcation procedure, bvFTD was not well
separated from PSP, which is interesting in view of the
phenotypic overlap, given that PSP can present cognitive
and behavioural change and many patients with bvFTD
later develop a supranuclear gaze palsy and/or parkinson-
ism (Burrell et al., 2014; Coyle-Gilchrist et al., 2016;
Ho¨glinger et al, 2017). Here, both PSP and bvFTD were
associated with loss of low frequency connectivity, in keep-
ing with animal models of tau-mediated FTLD. For ex-
ample, PLB2-tau mice show absolute power reductions in
alpha band (9–14Hz) in frontal and parietal locations
(Koss et al., 2016).
Network-based biomarkers of
neurodegeneration
The connectivity approach is ideally suited to the distribu-
ted nature of neuropathology and the impact of disease on
the axon and synapse. Covariance-based resting state net-
works identiﬁed from MEG/EEG are reliable and sensitive
to a wide range of neurodegenerative diseases (Stam, 2010;
Hughes and Rowe, 2013). However, our use of directed
graphs, or effective connectivity embodying directionality,
extends this work and accommodates potential asymme-
tries in large-scale brain networks. MEG and EEG allow
one to identify reciprocal connections across a range of
frequencies: this makes them well suited to characterize
the impact of dementia on connectivity in vivo, while main-
taining compatibility with invasive electrophysiological stu-
dies of networks (Muthukumaraswamy, 2014; Phillips
et al., 2015).
We used PDC to quantify connectivity, a method related
to Granger causality. PDC estimates directional connectiv-
ity between regions based on their functional time series.
An advantage of this method for MEG/EEG is that it is less
sensitive to the ﬁeld spread that otherwise inﬂates instant-
aneous correlation metrics (Baccala´ and Sameshima, 2001;
van Dellen et al., 2013; Colclough et al., 2016). When
combined with the focal ﬁeld-of-view of planar gradiom-
eters, simulation studies conﬁrm that multivariate autore-
gressive modelling minimizes ﬁeld spread while remaining
veridical to source–space interactions (Pereira et al., 2017).
Indeed, our own simulations conﬁrmed that this approach
can recover average local efﬁciency of source-level net-
works, provided signal-to-noise ratio is sufﬁciently high
(Supplementary Fig. 2). The use of sensor-level PDC
avoids the extra assumptions that are needed to optimize
the electromagnetic ‘inverse problem’ (Baillet et al., 2001).
However, we acknowledge that planar gradiometers are
only sensitive to relative superﬁcial cortical activity, and
we may have missed the effects of disease in deeper brain
structures (such information might be present in magnet-
ometer data, but would require source reconstruction to
infer network properties).
PDC informed the graph theoretical measures of network
function. Graph theory reveals fundamental properties of
brain network organization in health and has shown hom-
ologous vulnerabilities across many neurological and psy-
chiatric disorders (Stam, 2014). The network-level
description supports comparisons across modalities, scales
and disorders (Fornito et al., 2015). There are many meas-
ures of global network properties, such as small-worldness
or global efﬁciency, but we focus here on local efﬁciency
for two reasons. First, many neurodegenerative diseases are
characterized by regional rather than global pathology.
Second, it describes the local information transfer and re-
silience of a network. Third, previous studies have sug-
gested that local efﬁciency, and its counterpart of local
clustering, are impaired by neurodegeneration and can be
sensitive to pathology even in the absence of focal atrophy
(Stam, 2014). Recent neuroimaging-based network models
have identiﬁed local network efﬁciency as one of the stron-
gest indicators of underlying pathology in Alzheimer’s dis-
ease and frontotemporal dementia (Medaglia et al., 2017).
These properties make it ideal to elucidate the mechanisms
of lobar neurodegenerative disorders with differing atrophic
burdens (Seeley et al., 2009; de Haan et al., 2012a; van
Dellen et al., 2013; Stam, 2014; Hughes et al., 2015). It
should be noted that our measures of local efﬁciency are
derived from directed, but binarized, connections. The dir-
ection of connections is important because it affects the
local efﬁciency measure. It is possible that weighted
(rather than binarized) connections would further inform
graph metrics, but one cannot compare PDC values
across different sending sensors, so binarization is required
(which we implemented here by thresholding the highest
85% of PDC values).
There are limitations to our study. Severe atrophy is
characteristic of typical Alzheimer’s disease, PCA and
bvFTD (Rabinovici et al., 2007; Crutch et al., 2012;
Whitwell and Josephs, 2012), and this might inﬂuence the
sensors’ sensitivity to cortical sources and their
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connectivity. However, focal cortical atrophy in PSP and
navPPA is usually mild or absent (Cope et al., 2018),
even though it can be evident in group studies (Ghosh
et al., 2012; Mandelli et al., 2016). Moreover, a simple
loss of sensitivity due to atrophy would not be a sufﬁcient
explanation of our results. The selective impairment of cer-
tain frequency bands suggests that our results are not
merely a result of volume loss and increased distance
from source to sensor: this is likely to affect all frequencies
and be less reduced in PSP and navPPA (Bastos and
Schoffelen, 2016). The frequency-speciﬁcity of group differ-
ences also argue against a simple model of cortical oscilla-
tory dynamics in which higher frequencies are nested in
low frequency oscillations (Lakatos et al., 2008; Lisman
and Jensen, 2013). This may be due to the selective
impact of Alzheimer’s disease and FTLD on superﬁcial
and deep cortical layers, or to the selective breakdown of
the neurochemical modulation of brain states (Uhlhaas and
Singer, 2006; Murley and Rowe, 2018).
Our analyses focus on sensor space using planar gradi-
ometers, rather than magnetometres or attempting to re-
construct source space activity. Several methods exist that
reconstruct source space activity. However, the accuracy of
these methods in conjunction with graphical network ana-
lysis is not yet established, and the good approximation of
planar gradiometer topography to underlying cortical
sources provides sufﬁcient resolution to test our current
hypotheses. Simulation studies conﬁrm that multivariate
auto-regression modelling is more robust in sensor space
(Michalareas et al., 2013), while the use of lagged inter-
action measures from planar gradiometer data are less sen-
sitive to ﬁeld-spread (Pereira et al., 2017). Our own
simulations provided further evidence that the analysis of
sensor space graph metrics accords with source space gen-
erators of the data.
Another limitation is that our groups are deﬁned by
clinical diagnostic criteria, without pathological or genetic
conﬁrmation except for PSP. However, all our patient par-
ticipants had well established disease, not peri-symptomatic
or mild cognitive impairment. With this degree of severity,
the clinicopathological correlations are high for PSP, typical
Alzheimer’s disease, and PCA. Pathology would be of inter-
est in bvFTD to differentiate those with tau versus TDP43
pathology, although consensus clinical diagnostic criteria
are reliable in separating bvFTD from Alzheimer’s disease.
There are potentially signiﬁcant effects of age on MEG-
derived power spectra (Tsvetanov et al., 2015). These
might confound the PCA results, being younger than
other groups, although such age effects would not explain
the spectral ‘similarity’ between PCA and typical
Alzheimer’s disease, or the differences between typical
Alzheimer’s disease and other groups.
In conclusion, the local efﬁciency of cortical networks
was impaired by each of ﬁve neurodegenerative syndromes
resulting from Alzheimer’s disease and FTLD. The ﬁve dis-
orders had distinctive proﬁles in terms of their distribution
and frequency of oscillatory activity. Pattern classiﬁcation
using the spatiotemporal map of connectivity differentiated
the ﬁve disorders. The frequency range of the loss of local
efﬁciency was distinguished by the likely underlying path-
ology, while the anatomical distribution related to the clin-
ical syndrome. These ﬁndings enrich preclinical models of
the physiological consequence of neuropathology, and link
clinical in vivo measures to preclinical models of degener-
ation. They also provide potential physiological biomarkers
with which to assess pre-symptomatic network dysfunction
in early stage disease and for tracking disease progression
or disease-modifying therapies in experimental medicine
studies.
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